FERRISELTZ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ferriseltz, and what generic alternatives are available?
Ferriseltz is a drug marketed by Otsuka and is included in one NDA.
The generic ingredient in FERRISELTZ is ferric ammonium citrate. There are twenty drug master file entries for this compound. Additional details are available on the ferric ammonium citrate profile page.
Summary for FERRISELTZ
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FERRISELTZ at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FERRISELTZ
US Patents and Regulatory Information for FERRISELTZ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka | FERRISELTZ | ferric ammonium citrate | FOR SOLUTION;ORAL | 020292-001 | Oct 14, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |